Physician profile
David Sved
NPI 1497316384
$10,512.01
in general payments reported to CMS, 2019-2025
15 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,623 · 2020: $1,424 · 2021: $1,460 · 2022: $4,370 · 2023: $1,311 · 2024: $160 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $857 · Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $856.72 |
| Food and Beverage | $779.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,329.65 | 2020-2024 | Inbone, Infinity, Infinity Adaptis |
| Great Lakes Orthopedics | $2,464.43 | 2019-2022 | |
| Paragon 28, INC. | $1,261.19 | 2020-2023 | Portfolio |
| Crossroads Orthopedics, LLC | $1,200.00 | 2022 | |
| Arthrex, INC. | $963.66 | 2023 | |
| Smith+Nephew, INC. | $259.63 | 2021-2025 | Grafix Pl, Oasis, Stravix Pl |
| Organogenesis INC. | $239.23 | 2021-2023 | Puraply |
| Horizon Therapeutics Plc | $206.20 | 2019-2021 | |
| Enduromed, LLC | $187.17 | 2023-2025 | |
| Integra Lifesciences Corporation | $175.97 | 2021-2022 | |
| Amniox Medical, INC. | $57.83 | 2020 | |
| Medical Device Business Services, INC. | $56.06 | 2019 | |
| Depuy Synthes Sales INC. | $46.00 | 2019 | |
| Bone Support INC. | $34.22 | 2019 | |
| Zimmer Biomet Holdings, INC. | $30.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sved listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.